arrow
M

Minghui Duan

北京协和医学院
H指数:27
被引数:2,585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy

格卡罗替尼、非达替尼、帕克里替尼和莫美洛替尼在二线骨髓纤维化治疗中的匹配调整间接比较

2026-09-300
PRE
2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis

2g/m² Ara-c相比1g/m² Ara-c在CLAG治疗方案中对难治或复发性急性髓系白血病的治疗效果更优,且未增加毒性:一项多中心倾向性评分匹配分析

2026-03-230
OAAI
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional Survey
2025-10-010
PRE
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms

MPN Asia 2025亮点:髓系增殖性肿瘤的分子发病机制和治疗策略进展

2025-07-120
OA
Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3RT61sI : A Multi-Centre Retrospective Study

与CSF3RT61sI相关慢性中性粒细胞白血病患者结局相关的变量:一项多中心回顾性研究

BLOOD
IF23.1
2024-11-050
PRE